SWP
LLY icon

Stratos Wealth Partners’s Eli Lilly LLY Stock Holding History

Stratos Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.5M Buy
33,151
+6,107
+23% +$6.19M 0.35% 50
2025
Q4 		$29.1M Sell
27,044
-5,266
-16% -$5.04M 0.33% 57
2025
Q3 		$24.7M Buy
32,310
+1,183
+4% +$880K 0.29% 69
2025
Q2 		$24.3M Sell
31,127
-1,255
-4% -$975K 0.33% 58
2025
Q1 		$26.7M Sell
32,382
-2,129
-6% -$1.77M 0.41% 49
2024
Q4 		$26.6M Sell
34,511
-1,111
-3% -$920K 0.38% 50
2024
Q3 		$31.6M Buy
35,622
+415
+1% +$373K 0.46% 38
2024
Q2 		$31.9M Sell
35,207
-515
-1% -$412K 0.51% 30
2024
Q1 		$27.8M Buy
35,722
+1,343
+4% +$956K 0.46% 36
2023
Q4 		$20M Buy
34,379
+1,948
+6% +$1.14M 0.37% 43
2023
Q3 		$17.4M Buy
32,431
+3,472
+12% +$1.79M 0.38% 44
2023
Q2 		$13.6M Buy
28,959
+3,506
+14% +$1.47M 0.31% 62
2023
Q1 		$8.74M Buy
25,453
+1,582
+7% +$534K 0.23% 93
2022
Q4 		$8.73M Sell
23,871
-1,365
-5% -$484K 0.22% 95
2022
Q3 		$8.16M Sell
25,236
-642
-2% -$203K 0.23% 89
2022
Q2 		$8.39M Buy
25,878
+653
+3% +$196K 0.21% 99
2022
Q1 		$7.22M Sell
25,225
-22
-0.1% -$5.66K 0.16% 128
2021
Q4 		$6.97M Buy
25,247
+2,837
+13% +$719K 0.15% 140
2021
Q3 		$5.18M Sell
22,410
-93
-0.4% -$23K 0.13% 177
2021
Q2 		$5.17M Buy
22,503
+8,039
+56% +$1.61M 0.13% 181
2021
Q1 		$2.7M Buy
14,464
+441
+3% +$86.3K 0.07% 242
2020
Q4 		$2.37M Buy
14,023
+849
+6% +$127K 0.07% 254
2020
Q3 		$1.95M Sell
13,174
-166
-1% -$25.7K 0.06% 266
2020
Q2 		$2.19M Buy
13,340
+1,440
+12% +$221K 0.08% 246
2020
Q1 		$1.65M Buy
11,900
+622
+6% +$85.5K 0.08% 245
2019
Q4 		$1.48M Buy
11,278
+28
+0.2% +$3.25K 0.06% 302
2019
Q3 		$1.26M Sell
11,250
-1,119
-9% -$125K 0.05% 321
2019
Q2 		$1.37M Sell
12,369
-1,925
-13% -$227K 0.06% 287
2019
Q1 		$1.85M Buy
14,294
+3,543
+33% +$431K 0.08% 244
2018
Q4 		$1.24M Sell
10,751
-254
-2% -$28.4K 0.06% 287
2018
Q3 		$1.18M Sell
11,005
-1,518
-12% -$152K 0.05% 299
2018
Q2 		$1.07M Sell
12,523
-426
-3% -$35K 0.05% 348
2018
Q1 		$1M Buy
12,949
+1,456
+13% +$117K 0.04% 370
2017
Q4 		$971K Buy
11,493
+220
+2% +$18.7K 0.04% 354
2017
Q3 		$964K Sell
11,273
-633
-5% -$51.9K 0.05% 341
2017
Q2 		$980K Buy
11,906
+1,681
+16% +$137K 0.05% 300
2017
Q1 		$860K Buy
10,225
+585
+6% +$46.9K 0.05% 307
2016
Q4 		$709K Sell
9,640
-1,914
-17% -$143K 0.04% 318
2016
Q3 		$927K Buy
11,554
+2,821
+32% +$226K 0.06% 250
2016
Q2 		$688K Buy
8,733
+2,002
+30% +$151K 0.05% 278
2016
Q1 		$485K Buy
6,731
+653
+11% +$49.4K 0.04% 300
2015
Q4 		$512K Sell
6,078
-224
-4% -$18.6K 0.04% 300
2015
Q3 		$528K Sell
6,302
-728
-10% -$61.5K 0.07% 250
2015
Q2 		$586K Sell
7,030
-9,168
-57% -$699K 0.08% 234
2015
Q1 		$1.18M Sell
16,198
-1,067
-6% -$76K 0.14% 149
2014
Q4 		$1.19M Buy
17,265
+2,204
+15% +$149K 0.21% 113
2014
Q3 		$977K Sell
15,061
-72
-0.5% -$4.56K 0.23% 100
2014
Q2 		$940K Buy
+15,133
New +$903K 0.31% 93

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stratos Wealth Partners's LLY Position: Q1 2026 in Review

Stratos Wealth Partners increased its Eli Lilly (LLY) stake by 23% in Q1 2026, buying an estimated $6.19M and bringing the position to 33,151 shares worth $30.5M. The position accounts for 0.35% of the portfolio, ranked #50.

Stratos Wealth Partners first reported a position in LLY in Q2 2014 and has held it in 48 quarters since. The position peaked at $31.9M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Stratos Wealth Partners held 33,151 shares of Eli Lilly worth $30.5M as of Q1 2026.
  • Stratos Wealth Partners bought 6,107 Eli Lilly shares in Q1 2026, an estimated $6.19M.
  • Eli Lilly made up 0.35% of Stratos Wealth Partners's portfolio in Q1 2026, its #50 holding.
  • Stratos Wealth Partners first reported a position in Eli Lilly in Q2 2014 and has held it in 48 quarters since.
  • Stratos Wealth Partners's Eli Lilly position peaked at $31.9M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.